Shabnam Azadeh Ford, Ph.D.
About Shabnam Azadeh Ford, Ph.D.
Shabnam Azadeh Ford, Ph.D., serves as an Adjunct Assistant Professor at George Washington University and has a background in biostatistics and statistical analysis, having previously worked at the FDA and UT MD Anderson Cancer Center.
Current Position at George Washington University
Shabnam Azadeh Ford, Ph.D., serves as an Adjunct Assistant Professor at George Washington University. She has held this position since 2016, contributing to the academic environment in Washington, District of Columbia. Her role involves teaching and mentoring students, leveraging her extensive background in biostatistics and health services research.
Previous Experience at UT MD Anderson Cancer Center
Ford worked at UT MD Anderson Cancer Center from 2012 to 2015 as a Graduate Research Assistant in the Department of Biostatistics. During this three-year tenure, she engaged in research projects that contributed to the understanding of statistical methods in cancer research. Additionally, she served as a Pre Doctoral Trainee at the same institution, further enhancing her expertise in biostatistics.
Experience at The University of Texas Health Science Center at Houston
At The University of Texas Health Science Center at Houston, Ford held multiple roles. She worked as a Graduate Research Assistant at The Center for Health Services Research for three months in 2011-2012. Additionally, she served as a Graduate Teaching Assistant at the School of Public Health from 2010 to 2012, where she supported the educational mission of the institution.
Education and Expertise in Biostatistics
Ford earned her Doctor of Philosophy (Ph.D.) in Biostatistics from The University of Texas Health Science Center at Houston, completing her studies from 2010 to 2015. Her academic background provides a strong foundation for her research and teaching roles, particularly in the areas of statistical analysis and health services research.
Role at FDA as Mathematical Statistician
Shabnam Azadeh Ford has worked as a Mathematical Statistician at the FDA since 2016. She initially held this position until 2022, after which she resumed the role in 2022. Her work at the FDA involves applying statistical methods to support regulatory decisions and ensure public health safety.